Alector, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 06:00:00 01/07/26 am AEST			5-day change	1st Jan Change
2.010 ^USD	-3.37%		+9.84%	+28.85%

08/05	Alector, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06/05	Alector, Inc. - Special Call

Published on 09/23/2025 at 04:50 am AEST - Modified on 09/23/2025 at 11:05 am AEST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning, ladies and gentlemen, and welcome to Alector's conference call and webcast highlighting its progranulin franchise and Alector Brain

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

08/05	Alector, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
06/05	Alector, Inc. - Special Call
30/04	Alector to discontinue phase 2 trial of nivisnebart	RE
30/04	Alector Inc Discontinues Phase 2 Progress-Ad Trial of Nivisnebart and Provides Pipeline Update	CI
16/04	Alector Shares Rise After Cantor Fitzgerald Upgrade	MT
15/04	Cantor Fitzgerald Upgrades Alector to Overweight From Neutral	MT
13/03	Alector Files $400 Million Mixed Shelf	MT
11/03	Alector Shares Rise After BTIG Upgrade	MT
10/03	BTIG Upgrades Alector to Buy From Neutral, Price Target is $6	MT
07/03	Alector, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 03:10 PM
26/02	Alector, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
19/12	Alector, Inc.(NasdaqGS:ALEC) dropped from NASDAQ Biotechnology Index	CI
13/12	Alector Names Neil Berkley as CFO	MT
13/12	Alector, Inc. Appoints Neil Berkley as Chief Financial Officer, Effective December 10, 2025	CI
09/12	Alector, Inc. Presents at BofA Securities CNS Therapeutics Virtual Conference 2025, Dec-08-2025 02:25 PM